Biktarvy, formally known as biktarvy, represents a potent single-tablet regimen for controlling HIV infection. This drug integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the virus's ability to copy within the body, significantly decreasing the viral load. For many individuals,